Company intelligence / Profile preview

VXi

Conroe, Texas, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

VGXI is a leading contract development and manufacturing organization (CDMO) specializing in the production of high-quality plasmid DNA for the biopharmaceutical industry. With over 20 years of experience, the company provides cGMP manufacturing services for DNA vaccines, gene therapies, and RNA-based medicines. VGXI utilizes its proprietary, patented AIRMIX® lysis technology to ensure high levels of supercoiled DNA and exceptional purity in its products. Headquartered in Conroe, Texas, the company operates a state-of-the-art manufacturing facility and serves as a key subsidiary of GeneOne Life Science.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Plasmid DNADNA vaccineGene therapyRNA therapymRNA-based drugs
Industry: Contract Manufacturing Organization

Partnerships

National ResilienceCryoport

Beyond the preview

Go deeper on VXi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VXi.

Explore the full profile